U.S. Transportation Stock News

If you are wondering whether EMCOR Group is still fairly priced after its run, this article will walk through what the current market price could be telling you about its underlying value. With the share price at US$812.79 and returns of 1.5% over 7 days, 17.1% over 30 days, 27.3% year to date and 101.4% over 1 year, recent moves may have shifted how investors think about both upside potential and risk. Recent news coverage has focused on EMCOR Group as a key listed player in construction...

If you are wondering whether East West Bancorp's current share price lines up with its underlying worth, you are not alone. This article is built to help you answer that. The stock most recently closed at US$121.31, with returns of 3.0% over 7 days, 8.9% over 30 days, 5.4% year to date, 32.6% over 1 year, 71.9% over 3 years, and 90.6% over 5 years, which may have shifted how some investors view its potential and risk. Recent coverage around East West Bancorp has focused on its role as a...

Cinemark Holdings (CNK) is back in focus after reporting its fourth quarter and full year 2025 results, along with a fresh quarterly dividend declaration and an update on recently completed share repurchases. See our latest analysis for Cinemark Holdings. At a share price of US$25.90, Cinemark has seen a 7-day share price return of 4.10% and a 30-day share price return of 7.87%, while its 1-year total shareholder return of 2.94% decline contrasts with a strong 3-year total shareholder return...

Aurora Innovation (AUR) is back in focus after a fresh update on its autonomous trucking push, including 10 active routes, more than 250,000 driverless miles with zero collisions, and plans for 200 driverless trucks by 2026. See our latest analysis for Aurora Innovation. Aurora’s recent earnings update, shelf registration and progress on autonomous trucking routes have come alongside a 22.48% year to date share price return. The 1 year total shareholder return of 32.38% decline shows longer...

In February 2026, TransMedics Group, Inc. received full FDA approval of its Investigational Device Exemption for the Next-Generation OCS ENHANCE Heart trial, following earlier approvals for its DENOVO Lung IDE and a prior conditional ENHANCE Heart IDE. This two-part ENHANCE Heart study aims to enable prolonged heart perfusion and to show that OCS Heart perfusion in brain-death donations can outperform traditional static cold storage, potentially influencing clinical practice in heart...

With no single headline event driving attention, Enterprise Products Partners (EPD) is back on investors’ radar as its recent returns and valuation metrics prompt fresh questions about how the midstream partnership fits into income portfolios. See our latest analysis for Enterprise Products Partners. The share price at US$36.35 reflects a 10.0% 1 month share price return and 11.7% 3 month share price return, while the 1 year and 5 year total shareholder returns of 16.8% and 145.4% point to...

Ameren (NYSE:AEE) has appointed Timothy S. Rausch to its board of directors. Rausch brings extensive experience in nuclear generation and utility leadership. The appointment is intended to deepen the board's expertise in nuclear operations and sustainability. Ameren, the regulated utility serving electric and natural gas customers in the Midwest, is adding Rausch at a time when power companies are reassessing generation mix, grid reliability, and long term capital needs. His background in...

Kaiser Aluminum (KALU) is back in focus after reporting record 2025 EBITDA and net income, supported by higher margins, packaging investments, and detailed plans for 2026 spending, aerospace growth, and operational efficiency. See our latest analysis for Kaiser Aluminum. The recent earnings beat and record 2025 EBITDA have come after a sharp 38.61% 90 day share price return. However, the 7 day share price return of 8.11% shows some cooling, while the 1 year total shareholder return of 86.01%...

EchoStar (SATS) has drawn investor attention after recent share price swings, including a one-month return of around a 15% decline, alongside a gain of about 51% over the past three months, prompting closer scrutiny of its fundamentals. See our latest analysis for EchoStar. Those sharp moves sit alongside a 51.3% 3 month share price return and a 1 year total shareholder return of about 270%, which together suggest momentum has been strong recently, even after the latest pullback. If recent...

Citigroup (C) is back in focus for many investors after its recent trading performance, with the stock showing mixed returns over the past week, month, past 3 months, and year to date. See our latest analysis for Citigroup. With the share price now at US$116.0, Citigroup’s recent 4.6% 7 day share price return and 14.7% 90 day share price return sit alongside a much stronger picture over longer periods, with 1 year total shareholder return of 51.5% and 3 year total shareholder return of about...

General Dynamics (GD) stock is back in focus after the company secured a government contract worth US$255.13 million for the Strategic Weapon System Fire Control Subsystem, which will support U.S. and U.K. submarine fleets through 2033. See our latest analysis for General Dynamics. The new submarine fire control contract lands at a time when General Dynamics’ share price has eased 3.3% over the past month but remains supported by a 47.4% 1 year total shareholder return, suggesting longer term...

Concentrix partnership and bond deal put capital structure in focus Concentrix (CNXC) has paired a new partnership with cybersecurity firm Proofpoint with a fresh fixed income raise, giving investors more to assess around its growth plans and balance sheet. The company recently completed a US$599.796 million offering of 6.5% senior unsubordinated unsecured notes due March 1, 2029. The notes were priced at 99.966%, with a 0.35% discount per security, and are callable and unsecured. See our...

Hecla Mining (HL) is back in focus after record 2025 results, a planned sale of its Casa Berardi gold mine, and fresh 2026 production guidance that shifts its business further toward silver. See our latest analysis for Hecla Mining. The recent record 2025 results, higher 2026 silver guidance and dividend declarations have coincided with a sharp 66.11% 90 day share price return and a very large 1 year total shareholder return. However, the 30 day share price return of a 24.49% decline suggests...

If you are wondering whether Albany International's current share price reflects its underlying worth, you are not alone. This article focuses squarely on what you are getting for the price you pay. The stock last closed at US$59.44, with returns of 2.7% over 7 days, 3.3% over 30 days, 13.6% year to date, but a 24.3% decline over 1 year and a 38.9% decline over 3 years. These figures may have changed how the market views both its potential and its risks. Recent news around Albany...

If you are looking at M&T Bank and wondering whether the current share price still offers value, this article walks through what that price actually implies. The stock last closed at US$232.52, with returns of 1.7% over 7 days, 8.7% over 30 days, 14.0% year to date, 23.8% over 1 year, 64.9% over 3 years and 79.3% over 5 years. These figures can change how investors think about both upside and risk. Recent attention on regional banks and their balance sheet strength has kept M&T Bank on many...

Why Synopsys stock is drawing attention now Synopsys (SNPS) is back on many investors’ radars after a recent pullback, with the share price down about 16% over the past month and roughly 10% over the past year. See our latest analysis for Synopsys. The 16.1% 30 day share price decline continues a weaker short term trend, although the 3 year total shareholder return of 15.8% and 5 year total shareholder return of 65.6% show a very different, longer term picture. If Synopsys has you thinking...

In recent weeks, Tetra Tech, Inc. has announced multiple long-term contracts, including a US$100 million, 5-year AFCEC award, new U.S. Army Corps of Engineers architectural and engineering work, and a mandate from the Netherlands’ Rijkswaterstaat to modernize critical water infrastructure. Together, these wins highlight Tetra Tech’s role in complex, resilience-focused infrastructure and environmental projects that lean heavily on its proprietary digital and analytics capabilities. Against...

Earlier this month, Boston Beer expanded its Sun Cruiser lineup by rolling out a new Blueberry Lemonade & Vodka flavor nationwide, refreshed its lemonade variety packs, and introduced a hybrid sampler pack combining top iced tea and lemonade offerings, while also announcing that Chief Marketing Officer Lesya Lysyj will step down in March 2026. This combination of new product extensions around Sun Cruiser and upcoming marketing leadership change lands just as the company faces flat demand...

Jumia Technologies (JMIA) has come into focus after reporting fourth quarter and full year 2025 results, with sales of US$61.4 million and a net loss of US$10.31 million in the quarter. See our latest analysis for Jumia Technologies. Even with the latest earnings showing higher sales and a smaller quarterly net loss, Jumia Technologies' recent 30 day share price return of a 34.91% decline and year to date share price return of a 34.61% decline contrast with a very large 1 year total...

Lemonade, Inc. reported its fourth-quarter and full-year 2025 results on 19 February 2026, with Q4 revenue of US$228.1 million and a net loss of US$21.7 million, while full-year revenue reached US$737.9 million and the full-year net loss was US$165.5 million, both showing smaller losses than the prior year. Management highlighted record gross profit, improving cash flow, and the rollout of an AI-enabled autonomous car insurance product as key milestones supporting its push toward improved...

GE HealthCare Technologies (GEHC) is back in focus after securing FDA 510(k) clearance for three MRI systems, including the helium-light SIGNA Sprint with Freelium, the SIGNA Bolt 3T scanner, and the AI-driven SIGNA One workflow platform. See our latest analysis for GE HealthCare Technologies. The recent FDA clearances arrive alongside a steady upswing in the share price, with a 7.66% 90 day share price return and a 12.84% three year total shareholder return. This comes even though the one...

Recent performance snapshot International Paper (IP) has drawn attention after recent trading, with the stock last closing at $46.87. Short term performance has been mixed, with a small 1 day gain alongside a 4.5% decline over the past week. See our latest analysis for International Paper. While the recent 7 day share price return of a 4.5% decline may look weak, the 90 day share price return of 24.69% and 3 year total shareholder return of 45.48% suggest momentum has been building over a...

The RealReal is reopening its redesigned flagship store in San Francisco’s Union Square after nearly three years. The two story location features expanded luxury resale offerings, personalized consignment services, and local collaborations. The move marks an increased physical retail presence in the company’s founding city and adds to efforts to revive the downtown core. For investors watching NasdaqGS:REAL, the reopening comes with the stock trading around $11.11 and showing a mixed return...

Remitly Global (RELY) is back in the spotlight after reporting its first full year of profitability, paired with strong Q4 2025 results, upbeat 2026 guidance, and a CEO handover to Sebastian Gunningham. See our latest analysis for Remitly Global. The upbeat Q4 2025 results, first full year of profitability and CEO transition have coincided with sharp momentum, with a 7 day share price return of 34.4% and a year to date share price return of 29.7%, even though the 1 year total shareholder...